Gennex Laboratories Ltd (531739) Stock Price & News

Why is 531739 down 2.69%?

Dive Deeper

531739:BOM

Gennex Laboratories Ltd

₹9.03

-2.69%

(-0.25) 1D

Oct 16, 3:30:00 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 531739...

Open

₹9.30

High

₹9.47

Low

₹8.90

Mkt. cap

2.19B

Avg. vol.

301.13K

Volume

842.21K

P/E ratio

10.42

52-wk high

₹17.25

52-wk low

₹7.05

EPS

₹0.87

Shares outstanding

126.50M

No. of employees

125

Open

₹9.30

High

₹9.47

Low

₹8.90

Mkt. cap

2.19B

Avg. vol.

301.13K

Volume

842.21K

P/E ratio

10.42

52-wk high

₹17.25

52-wk low

₹7.05

EPS

₹0.87

Shares outstanding

126.50M

No. of employees

125

Related stocks

PAR

Par Drugs and Chemicals Ltd

₹108.10

-2.81%

531726

Panchsheel Organics Ltd

₹106.40

+4.21%

530313

Kimia Biosciences Ltd

₹32.10

-4.35%

538964

Mercury Laboratories Ltd

₹755.00

-0.66%

News stories

From web sources and news partners

marketscreener.com

28 minutes ago

S&P 500 subdued as gains in banks offset AI jitters; Dow at one-month high

Bloomberg.com

1 hour ago

S&P 500 Steady as Warsh Boosts Expectations of Rate Hold

TradingView

1 hour ago

The Dow Jones Index Opens 0.48% Higher

Forbes

3 hours ago

S&P 500 Companies Talk About AI. Few Disclose How It's Controlled

About Gennex Laboratories Ltd

CEO-

Employees125

Founded1985

Headquarters-

SectorPharmaceutical industry

Websitegennexlab.com

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	372.42M	403.66M	609.55M	398.42M
Cost of goods sold	254.11M	282.96M	531.08M	296.37M
Cost of revenue	254.11M	282.96M	531.08M	296.37M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	18.38M	23.40M	20.62M	19.76M
Operating expense	68.01M	66.05M	30.17M	63.97M
Total operating expenses	322.11M	349.00M	561.25M	360.34M
Operating income	50.31M	54.66M	48.30M	38.08M
Other non operating income	20.60M	25.90M	-69.27M	20.08M
EBT including unusual items	60.62M	66.42M	46.68M	49.16M
EBT excluding unusual items	60.62M	69.42M	43.68M	49.16M
Income tax expense	5.50M	6.50M	2.09M	2.50M
Effective tax rate	9.07%	9.79%	4.48%	5.08%
Other operating expenses	44.98M	37.46M	-2.06M	38.52M
Net income	50.32M	52.37M	61.18M	46.66M
Net profit margin	13.51%	12.97%	10.04%	11.71%
Earnings per share	-	-	-	-
Interest and investment income	-	-	71.38M	-
Interest expense	-10.29M	-11.14M	-10.77M	-9.00M
Net interest expenses	-10.29M	-11.14M	60.61M	-9.00M
Depreciation and amortization charges	4.65M	5.18M	11.61M	5.69M
EBITDA	55.15M	59.64M	54.92M	44.70M
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything